Protein misfolding, amyotrophic lateral sclerosis and guanabenz: protocol for a phase II RCT with futility design (ProMISe trial).
about
Protein misfolding, amyotrophic lateral sclerosis and guanabenz: protocol for a phase II RCT with futility design (ProMISe trial).
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Protein misfolding, amyotrophi ...... tility design (ProMISe trial).
@en
type
label
Protein misfolding, amyotrophi ...... tility design (ProMISe trial).
@en
prefLabel
Protein misfolding, amyotrophi ...... tility design (ProMISe trial).
@en
P2093
P2860
P50
P921
P1433
P1476
Protein misfolding, amyotrophi ...... tility design (ProMISe trial).
@en
P2093
Claudia Caponnetto
Eleonora Dalla Bella
Enrico Granieri
Fabio Giannini
Gabriele Siciliano
Gianni Sorarù
Giovanni Antonini
Giuseppe Lauria
Irene Tramacere
Isabella Simone
P2860
P304
P356
10.1136/BMJOPEN-2016-015434
P577
2017-08-11T00:00:00Z